Purchases and Sales Made in Q1 2023 in Vallon Pharmaceuticals, Inc. (VLON)
This table provides information about the institutional ownership of Vallon Pharmaceuticals, Inc. (VLON) during Q1 2023. The information is specifically focused on institutions that hold shares of Vallon Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
15.1KNew |
$4.08K - $13.3K
|
15.1K
$0
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
11.1KNew |
$3K - $9.76K
|
11.1K
$0
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.75% |
$0.27 - $0.88
|
58
$0
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2023
Q1 2023
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-13.9K- 37.96% |
$3.75K - $12.2K
|
22.7K
$0
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-17.4K- 85.65% |
$4.71K - $15.3K
|
2.92K
$0
|